Chawla Lakhmir S 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Jul 17, 2020
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-07-15+521→ 521 totalExercise: $4.44Exp: 2030-07-15→ Common Stock (521 underlying) - Award
Common Stock
2020-07-15$3.77/sh+521$1,964→ 11,441 total
Footnotes (2)
- [F1]These shares were acquired on 07/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vest and become exercisable ratably on a monthly basis over the next three years.